NMRmetabolomics

Liposcale for early and reliable diagnosis and prognosis of breast cancer patients

One of the key features of malignant tumour cells is that their energy metabolism is altered. However, in recent years, alterations in lipid metabolism have been described in some types of cancer. A study led by the team of Dr. Josep Gumà and Dr. Sandra Guaita from the Pere Virgili Health Research Institute (IISPV) and… Read More »Liposcale for early and reliable diagnosis and prognosis of breast cancer patients

Liposcale Breast cancer

Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test

Patients with chronic kidney disease (CKD) have a high burden of atheromatous cardiovascular disease (ASCVD) that is not fully explained by traditional lipid parameters. A study published in the clinical Kidney journal, conducted in patients with chronic kidney disease, reveals that information on lipoprotein composition and subclass particle number using the Liposcale test could improve… Read More »Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test

malaltia cardiovascular ateromatosa

Biosfer Co-Leads a project to implement the first in vitro prognostic test for covid-19.

The Agency for the Management of University and Research Grants (AGAUR) has awarded the grant for the funding of research projects PANDÈMIES 2020 to the MiL@b research group of the IISPV, the URV and the spin-off Biosfer Teslab, SL. The call granted has been “Replegar-se per crèixer: l’impacte de les pandèmies en un món sense… Read More »Biosfer Co-Leads a project to implement the first in vitro prognostic test for covid-19.

Covid-19

Nuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsia

Dr. Amor and collaborators have published a new article in the Diabetes Research and Clinical Practice journal using our plasma metabolomics analysis. The aim of the study was to evaluate the role of plasma metabolomics in atherosclerosis according to the presence of type 1 diabetes (T1D) or previous preeclampsia. They have concluded that plasma metabolomics… Read More »Nuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsia